ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 122,05
-0,13%
Dow Jones
39 069,59
0,01%
DAX
18 847,44
0,46%
Brent Oil
83,065
0,27%
Bitcoin
68 037,97
-1,95%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. First Horizon Pharmaceutical (MM) (FHRX)

  7. First Horizon Pharmaceutical (MM) (FHRX) Actualités

FHRX

First Horizon Pharmaceutical (FHRX)

First Horizon Pharmaceutical (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FHRX
DateHeureSourceTitreSymboleSociété
15/06/200619h35Business WireFirst Horizon Pharmaceutical Corporation Stockholders Approve Name Change to Sciele Pharma, Inc.NASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
14/06/200614h30Business WireFirst Horizon Receives FDA Orphan Drug Designation for Its Glycopyrrolate to Treat Chronic Drooling in Pediatric PatientsNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
22/05/200614h00PR Newswire (US)SkyePharma to Develop Improved Controlled Release Version of Sular for First HorizonNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
17/05/200614h15Business WireFirst Horizon Pharmaceutical CorporationNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
03/05/200614h35Business WireFirst Horizon Pharmaceutical Corporation Increases Adjusted Diluted Earnings Per Share (EPS) Guidance by $0.10 to $1.27-$1.32 fNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
03/05/200614h30Business WireFirst Horizon Pharmaceutical Corporation Announces Expiration of and Successful 100% Participation in Its Exchange Offer for ItNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
28/04/200616h22Business WireFirst Horizon to Present at Deutsche Bank Securities 31st Annual Health Care ConferenceNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
26/04/200622h06Business WireFirst Horizon Pharmaceutical Reports Revenue and EPS Growth for the First Quarter 2006NASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
19/04/200612h00Business WireFirst Horizon Pharmaceutical Corporation Announces Extension and Modification of Its Exchange Offer for Its Outstanding 1.75% CNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
12/04/200622h10Business WireFirst Horizon Announces First-Quarter 2006 Earnings Release Date and Conference CallNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
03/04/200622h30Business WireFirst Horizon Pharmaceutical Corporation Names Ed Schutter as New Executive Vice President, Chief Commercial OfficerNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
31/03/200615h45Business WireFirst Horizon Pharmaceutical Corporation Added to Standard & Poor's SmallCap 600 IndexNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
30/03/200601h57PR Newswire (US)Standard & Poor's Announces Changes to U.S. IndicesNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
21/03/200614h59Business WireFirst Horizon Pharmaceutical Corporation Makes AnnouncementNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
16/03/200623h44Business WireFirst Horizon Pharmaceutical Corporation Commences Exchange Offer for Its Outstanding 1.75% Contingent Convertible Senior SuborNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
28/02/200612h41Business WireFirst Horizon Announces Filing of Registration Statement for a Proposed Exchange Offer for its 1.75% Contingent Convertible SenNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
23/02/200622h01Business WireFirst Horizon Announces Results for the Fourth Quarter and Year Ended December 31, 2005 and Provides Updated 2006 GuidanceNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
08/02/200616h22Business WireFirst Horizon to Present at Deutsche Bank Securities Small Cap Growth ConferenceNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
25/01/200622h17Business WireFirst Horizon Announces Year-End 2005 Earnings Release Date and Conference CallNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
19/01/200614h00PR Newswire (US)Open-Label Study Shows No Significant Effects on the Pharmacokinetics of a Single Dose of TRIGLIDE(TM) (Fenofibrate) Tablets WheNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
09/01/200616h27Business WireFirst Horizon Continues to Grow Its Partnership with Bayer HealthcareNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
06/01/200619h05Business WireFirst Horizon to Present at JPMorgan 24th Annual Healthcare ConferenceNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
26/10/200522h02Business WireFirst Horizon Announces Results for the Third Quarter and Nine Months Ended September 30, 2005 and Provides Updated 2005 and 200NASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
17/10/200514h17Business WireFirst Horizon Announces Third-Quarter 2005 Earnings Release Date and Conference CallNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
29/08/200514h49Business WireFirst Horizon to Present at the 2005 Thomas Weisel Partners Health Care ConferenceNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
20/07/200513h00Business WireFirst Horizon to Present At the Banc of America Securities Specialty Pharmaceuticals ConferenceNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
14/07/200522h29Business WireFirst Horizon Announces Second-Quarter 2005 Earnings Release Date and Conference CallNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
09/05/200514h00PR Newswire (US)SkyePharma Receives FDA Approval For Triglide(TM) A Novel Formulation Of FenofibrateNASDAQ:FHRX
09/05/200513h00Business WireFirst Horizon Pharmaceutical Corporation Announces That FDA Approves Triglide, a Novel Formulation of FenofibrateNASDAQ:FHRXFirst Horizon Pharmaceutical (MM)
01/02/200513h00PR Newswire (US)SkyePharma and First Horizon Extend Agreement for Novel Formulation of FenofibrateNASDAQ:FHRX
 Showing the most relevant articles for your search:NASDAQ:FHRX

Dernières Valeurs Consultées

NASDAQ
FOJAJX
Tactical Income Portfoli...
USOTC
HWKRF
Earthwise Minerals (PK)
LSE
XDGU
X$corpbond
CSE
LAI.X
La Imperial Resources
EU
XS2637963146
ABN AMRO 3875% until 12/...
EU
5553T
5553T
BIT
F19418
Vontobel Financial Produ...
GATE
ITSBETH
ITSBLOC
TSXV
BFK.P@OL
USOTC
FDOCD
Charging Robotics (PK)
BIT
F13773
Vontobel Financial Produ...
HUOB
SOLUSDT
Solana
COIN
BIZBTC
USOTC
CAOYF
China Aoyuan (CE)
USOTC
CHSTF
China High Speed Transmi... (PK)
USOTC
XALL
Xalles (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés